Redbiotec AG announces today the appointment of Prof. Dr. Ralf Wagner, founder of Geneart, to Redbiotec’s team. We are both proud and pleased that Dr. Wagner joined our Company as scientific advisor. With his strong background in synthetic biology and vaccines he will strengthen our leading position in VLP vaccines. In addition to his scientific background, Ralf Wagner has a notable track record as entrepreneur. In 1999 he co-founded Geneart and brought it public to the German stock market in 2006, followed by a successful tradesale of Geneart to the US company Life Technologies (formerly Invitrogen) in 2010. Redbiotec is convinced that it will profit a lot from Ralf Wagner in the continuation of its leading business.
